Benzodiazepines and Anxiolytics
Benzodiazepines enhance GABAergic inhibition for rapid anxiolytic, sedative, and anticonvulsant effects. Their dependence potential has shifted prescribing toward safer long-term alternatives.
## Mechanism of Action
Benzodiazepines bind to a specific allosteric site on the GABA-A receptor (the benzodiazepine binding site between alpha and gamma subunits), increasing the frequency of chloride channel opening in response to GABA. This enhances inhibitory neurotransmission without directly activating the receptor, which is why benzodiazepines alone rarely cause fatal respiratory depression (unlike barbiturates, which increase the duration of channel opening and can directly activate the receptor).
## Classification by Duration
| Duration | Agent | Half-Life | Primary Use |
|----------|-------|-----------|-------------|
| Ultra-short | Midazolam | 1.5-2.5 h | Procedural sedation |
| Short | Alprazolam | 6-12 h | Panic disorder |
| Short | Lorazepam | 10-20 h | Acute anxiety, status epilepticus (IV) |
| Intermediate | Temazepam | 8-22 h | Insomnia |
| Long | Diazepam | 20-100 h | Seizures, alcohol withdrawal, muscle spasms |
| Long | Clonazepam | 18-50 h | Panic disorder, seizures |
Short-acting agents carry higher abuse potential and worse rebound symptoms. Long-acting agents accumulate in elderly patients, increasing fall risk.
## Clinical Uses
- **Anxiety disorders** -- Rapid relief while waiting for SSRIs to take effect. Intended for short-term use (2-4 weeks).
- **Insomnia** -- Temazepam for sleep initiation; declining use due to alternatives.
- **Seizures** -- Diazepam (rectal/IV) and lorazepam (IV) are first-line for status epilepticus. Clonazepam for chronic epilepsy.
- **Alcohol withdrawal** -- Diazepam or chlordiazepoxide in symptom-triggered protocols to prevent seizures and delirium tremens.
- **Procedural sedation** -- Midazolam IV for its rapid onset and amnesia properties.
- **Muscle spasm** -- Diazepam for acute musculoskeletal spasm.
## Dependence and Withdrawal
Physical dependence develops within 2-4 weeks of continuous use. The withdrawal syndrome includes rebound anxiety, insomnia, tremor, perceptual disturbances, and in severe cases, seizures. Withdrawal severity correlates with duration of use, dose, and rate of tapering.
Safe discontinuation requires gradual dose reduction over weeks to months. Switching from a short-acting to long-acting agent (e.g., alprazolam to diazepam) before tapering smooths the withdrawal curve.
## Safer Alternatives
- **Buspirone** -- 5-HT1A partial agonist for generalized anxiety. No sedation, no dependence, no withdrawal. Takes 2-4 weeks for onset.
- **Hydroxyzine** -- Antihistamine with anxiolytic properties. Useful for acute anxiety without abuse potential.
- **Gabapentin/pregabalin** -- GABA analogs (actually bind voltage-gated calcium channels). Used off-label for anxiety; pregabalin has some dependence risk.
## Key Takeaways
- Benzodiazepines work immediately but carry significant dependence risk after 2-4 weeks.
- Use the lowest effective dose for the shortest duration necessary.
- Never stop benzodiazepines abruptly after prolonged use -- seizures can be life-threatening.
- SSRIs and buspirone are preferred for long-term anxiety management.